Global L-Arabinose Market is segmented By Type (Food Grade, Pharma Grade), By Application (Food and Beverages, Pharmaceuticals, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
L-Arabinose Market Overview
The Global L-Arabinose market is estimated to reach at a high CAGR during the forecast period (2024-2031).
L-Arabinose is an isomer that arises naturally and is an integral part of polysaccharides in plants. Important bacterial numbers consist of an inducible operon of arabinose that codes for a set of transporters and enzymes. This helps L-arabinose to be used in microbial cultures as a sole source of carbon. It is present in nature as a component of biopolymers, such as hemicellulose and pectin. The biomolecular study is ongoing on the L-arabinose operon, also known as the araBAD operon. To recognize, separate, and classify pentose sugar isomerase, L-Arabinose is substantially used as a substrate. In the bio-production of L-ribose, L-Arabinose is also used. L-Arabinose is primarily used in food & beverage and pharmaceutical applications. In-plant cell walls, like corn, wheat, rye, rice, sugar beets, and plant gums, L-Arabinose is a naturally occurring pentose. It is commonly spread as a part of complex nonstarch polysaccharides. In vitro experiments with porcine intestinal mucosa demonstrated an inhibitory effect of L-arabinose on intestinal sucrase activity.
L-Arabinose Market Scope
|
Metrics |
Details |
|
Market CAGR |
High |
|
Segments Covered |
By Type, By Application and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
North America |
|
Largest Market Share |
Asia Pacific |
To Get a Free Sample Click here
L-Arabinose Market Dynamics
The major factors propelling the L-Arabinose market's growth are the escalated use of L-Arabinose as a substitute for sugar in food and beverages and its added health benefits, making its utilization higher in the pharmaceutical industry. When introduced in the diet, the compound offers benefits such as a reduction in chances of heart disease, prevention of type-2 Diabetes, lowering of blood cholesterol level, and more. Thus, L-arabinose's increasing demand from the Pharmaceutical sector drives the market growth during the forecast period. About 463 million people (aged 20-79 years) lived with Diabetes in 2019, according to the International Diabetes Federation, and the figure is projected to grow to 700 million by 2045. During the forecast era, increasing demand for L-arabinose from the pharmaceutical industry is projected to drive L-arabinose's global market. Moreover, the addition of L-arabinose to a diet is beneficial to prevent obesity. Increasing demand from the food & beverages industry, led by L-arabinose's benefits, is expected to impact the global L-arabinose market shortly positively.
Use of L-Arabinose as a Substitute for Sugar
One of the main causes affecting obesity is known to be Sugar. L-arabinose is a natural maize cob sweetener that can be used as a food and beverage sugar substitute. People's eating patterns are unpredictable and unhealthy due to the growing intake of fast food and chemically added additives. This has resulted in increasing obesity cases across the globe. In 2018, 40 million children aged five years or younger worldwide were overweight or obese, according to the World Health Organisation (WHO). To curb sugar intake and tackle obesity, the health-conscious population is shifting towards natural ingredients and substituting Sugar, leading to a boost in market growth.
When used as a part of the diet, L-arabinose offers benefits such as reducing chances of development of heart diseases, lowering the blood cholesterol level, managing body weight and composition and preventing Type 2 diabetes. According to the International Diabetes Federation, approximately 463 million adults (aged 20–79 years) were living with Diabetes in 2019, and the number is expected to rise to 700 million by 2045. Rising demand for L-arabinose from the pharmaceutical sector is expected to drive the global L-arabinose market during the forecast period.
Lack of awareness among the population
Lack of awareness concerning L-Arabinose's health advantages among individuals is a key factor expected to curtail the growth of the global market over the forecast period. L-Arabinose is a non-caloric sugar that can regulate the metabolism of glucose and lipids and inhibit obesity. The effect of L-arabinose on metabolic syndrome, a combination of medical disorders that raise the risk of Diabetes and cardiovascular disease, has been defined in a few studies.
COVID-19 Impact Analysis on L-Arabinose Market
The outbreak of COVID-19 has negatively impacted the growth of the L-Arabinose market globally. The disruption in the supply chain has majorly impacted the growth of the market amidst the pandemic. Therefore, the COVID-19 pandemic has hampered the market value of the L-Arabinose market in 2020.
L-Arabinose Market Segmentation Analysis
Based on the Type, the L-Arabinose market has been classified into Food Grade and Pharma Grade.
The food-grade segment is projected to be the dominant segment in the market during the forecast period.
Food Grade dominated the global market in 2019, whereas the Pharma Grade is expected to present considerable growth shortly. The increasing use of L-Arabinose as a substitute for Sugar has made it a key ingredient in food and beverage processing. The increasing consumption of food and beverages, swift food, drives the demand for L-Arabinose during the forecast period.
L-Arabinose is segmented based on Application, which includes Food and Beverages, Pharmaceuticals, Others.
Food and Beverages are expected to dominate the L-Arabinose market.
Food and Beverages held the dominant position in the global market during the forecast period. The increasing utilization of L-Arabinose in the Food and Beverage Industry as a sugar substitute coupled with the boost in the food and beverage processing sector across the globe supports the segment growth during the forecast period. Moreover, Pharmaceutical is expected to project a considerable CAGR during the forecast period. L-Arabinose's added benefits, such as management of Cholesterol levels, prevention of diabetes and heart diseases, propels lucrative market growth opportunities during the forecast period. In metabolic diseases such as Diabetes and reduced tolerance to glucose, glycaemic regulation is important. L-arabinose blocks the hydrolysis of sucrose into glucose and fructose. When L-arabinose replaced sucrose in beverages, Sucrose substitution in cereal foods did not affect glucose responses, although, In a cocktail, L-arabinose without sucrose did not impact glucose responses. Therefore, it is possibly a successful idea to substitute sucrose with L-arabinose to lower glycaemic and insulin responses.
Global L-Arabinose Market Geographical Share
Based on geography, the study analyzes the L-Arabinose market globally, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
Asia-Pacific is expected to dominate the global L-Arabinose market.
Asia-Pacific held a dominant position in the global L-Arabinose market in 2019. In Asia-pacific, the boost in the Food and beverage sector has stirred the demand for L-Arabinose and the changing lifestyles and shift towards fast food culture. Moreover, North America is expected to represent significant growth in terms of value during the forecast period. The increasing use in the pharmaceutical sector is expected to propel market growth across the region. The L-Arabinose market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the increasing prevalence of major conditions such as heart diseases, obesity, Diabetes and more.
L-Arabinose Market Companies and Competitive Landscape
The L-Arabinose market is highly competitive, owing to the presence of big food brands. The key L-Arabinose players contributing to the growth of the global market include Danisco, Healtang, Nuara Biotech, Thomson Biotech, Xieli Biotechnology, MAK Wood, Futaste, Huakang Pharmaceutical, Lujian Biological, Longlive Biotechnology, among others. The major players are adopting new Type launch and expansion strategies for global growth in the L-Arabinose market.
L-Arabinose Syrup (Danisco):
Natural origin Rare Sugar Syrups are manufactured from sustainable wood-based or other biomass hydrolysates by aqueous chromatographic solvent-free separation. The L – Arabinose Syrup offered is natural and non-GMO with applications as flavor and food ingredient. A considerable number of the employees are engaged in developing new products for the international food industry. Today, the Group holds more than 9,300 active patents and patent applications. Their work led to the understanding of the mechanism of CRISPR, the bacterial antiviral defense. CRISPR is a prokaryotic immune system that is both adaptive and inheritable.
Type Portfolio: The Company’s portfolio comprises D-manose, D-Xylose Syrup LR, and among others
Why Purchase the Report?
- Visualize the L-Arabinose market segmentation composition by type, application, and region, highlighting the critical commercial assets and players.
- Identify commercial opportunities in the L-Arabinose market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of L-Arabinose market - level 3 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Type mapping in excel for the key Type of all major market players.
The global L-Arabinose market report would provide access to an approx.. 51 market data table, 45 figures and 180 pages.
Target Audience
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
